Idris I, Zhang R, Mamza JB, Ford M, et al. Significant reduction in chronic kidney disease progression with sodium glucose co-transporter-2 inhibitors compared to dipeptidyl peptidase-4 inhibitors in adults with type 2 diabetes in UK clinical setting: An observational outcomes study based on i Diabetes Obes Metab 2022 Jun 8. doi: 10.1111/dom.14799.
PMID: 35676798